Humana, Centene Maintain 2020 Guidance Despite Crisis

Humana Inc. and Centene Corp. are both maintaining their 2020 earnings outlook despite the emergence of the COVID-19 pandemic and economic contraction at the end of the first quarter. Centene’s earnings fell short of the Wall Street consensus projection for the first quarter, while Humana’s earnings exceeded forecasts.

Humana’s revenues increased to $18.9 billion, compared with $16.1 billion in the first quarter of 2019, and it reported $5.40 in adjusted earnings per share (EPS), beating the Wall Street consensus of $4.66 adjusted EPS. Centene’s first quarter revenues increased 41% year-over-year to $26 billion, up from $18.4 billion, and it reported an adjusted EPS of $0.86. Centene fell short of the consensus with $0.99 adjusted EPS. Both insurers affirmed their projections for the end of the year, with Humana forecasting adjusted EPS of $18.25 to $18.75 and Centene $4.56 to $4.76.

0 Comments
© 2023 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

injection-pen
November 22

Medicare Part D Coverage for Humira Biosimilars Has Inspector General’s Attention

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
November 22

News Briefs: Nearly 4.6M People Have Enrolled in ACA Exchange Plans for 2024

READ MORE
wall-street
November 22

Elevated Outpatient Care, No Recession: 2023 Has Surprised Analysts

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today